TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CERS

Cerus Corporation

Healthcare · Medical Devices

2.70$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Cerus Corporation (CERS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 57 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CERS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
40 47 38 45 46 51 43 52 53 58 54 57 222
18 21 17 20 20 23 18 23 25 28 26 28 106
22 26 21 25 26 27 25 29 28 30 28 30 115
17 14 14 15 14 15 17 19 16 16 15 14 61
16 17 20 19 18 19 20 21 19 21 20 20 79
27 25 29 29 27 29 31 32 27 30 28 31 117
-5.2 1.0 -8.0 -3.8 -1.0 -1.4 -5.9 -3.4 1.2 -0.6 -0.4 -1.9 -1.6
2.4 2.2 2.2 2.3 2.3 2.1 2.1 2.2 2.1 2.0 1.9 1.7 7.7
-7.2 -1.3 -9.6 -5.8 -2.9 -2.5 -7.6 -5.6 0.1 -2.1 -1.6 -2.9 -6.4
0.1 0.1 0.1 -0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4
-7.3 -1.3 -9.7 -5.8 -2.9 -2.5 -7.7 -5.7 0.0 -2.2 -1.6 -2.9 -6.8
-4.2 1.6 -6.8 -3.0 -0.2 -0.1 -5.2 -3.1 2.6 0.3 0.8 -0.7 2.9

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?